Roger C. Cornell

1.3k total citations
25 papers, 933 citations indexed

About

Roger C. Cornell is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Roger C. Cornell has authored 25 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Dermatology, 8 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Roger C. Cornell's work include Dermatology and Skin Diseases (10 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and Urticaria and Related Conditions (5 papers). Roger C. Cornell is often cited by papers focused on Dermatology and Skin Diseases (10 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and Urticaria and Related Conditions (5 papers). Roger C. Cornell collaborates with scholars based in United States and United Kingdom. Roger C. Cornell's co-authors include Richard B. Stoughton, Daniel J. Tanner, Edwin A. Peets, Hubert T. Greenway, Elise A. Olsen, Irving P. Crawford, William Crawford, Gerald M. Bordin, J. Corwin Vance and Kenneth A. Smiles and has published in prestigious journals such as Pharmacology & Therapeutics, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Roger C. Cornell

24 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger C. Cornell United States 15 635 304 286 115 110 25 933
A.D. Ormerod United Kingdom 17 261 0.4× 235 0.8× 134 0.5× 160 1.4× 42 0.4× 31 749
Victor H. Witten United States 13 413 0.7× 63 0.2× 186 0.7× 76 0.7× 74 0.7× 56 735
Jann Lübbe Switzerland 17 650 1.0× 78 0.3× 181 0.6× 107 0.9× 35 0.3× 32 1.1k
Dagmar Wilsmann‐Theis Germany 19 677 1.1× 739 2.4× 117 0.4× 78 0.7× 33 0.3× 68 1.1k
Morad Lahfa France 15 687 1.1× 285 0.9× 136 0.5× 30 0.3× 20 0.2× 21 1.0k
Annunziata Raimondo Italy 15 394 0.6× 378 1.2× 109 0.4× 63 0.5× 16 0.1× 46 791
Rita V. Patel United States 8 229 0.4× 228 0.8× 170 0.6× 43 0.4× 15 0.1× 15 538
M. J. D. Goodfield United Kingdom 17 318 0.5× 143 0.5× 321 1.1× 73 0.6× 11 0.1× 37 768
Андрис Рубинс Latvia 10 680 1.1× 205 0.7× 114 0.4× 12 0.1× 77 0.7× 25 860
Nordwig S. Tomi Germany 16 538 0.8× 237 0.8× 82 0.3× 50 0.4× 12 0.1× 26 815

Countries citing papers authored by Roger C. Cornell

Since Specialization
Citations

This map shows the geographic impact of Roger C. Cornell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger C. Cornell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger C. Cornell more than expected).

Fields of papers citing papers by Roger C. Cornell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger C. Cornell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger C. Cornell. The network helps show where Roger C. Cornell may publish in the future.

Co-authorship network of co-authors of Roger C. Cornell

This figure shows the co-authorship network connecting the top 25 collaborators of Roger C. Cornell. A scholar is included among the top collaborators of Roger C. Cornell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger C. Cornell. Roger C. Cornell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanner, Daniel J., Roger C. Cornell, Richard L. DeVillez, et al.. (1998). Mometasone furoate 0.1%—salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study. Clinical Therapeutics. 20(2). 283–291. 32 indexed citations
2.
Katz, H. Irving, Jane S. Lindholm, Jonathan Weiss, et al.. (1995). Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. Clinical Therapeutics. 17(3). 390–401. 30 indexed citations
3.
Cornell, Roger C. & Michael Baker. (1993). Dermal safety comparison of 0.05% desonide cream and 1.0% hydrocortisone cream. Current Therapeutic Research. 53(4). 356–359. 3 indexed citations
4.
Cornell, Roger C.. (1992). CLINICAL TRIALS OF TOPICAL CORTICOSTEROIDS IN PSORIASIS: CORRELATIONS WITH THE VASOCONSTRICTOR ASSAY. International Journal of Dermatology. 31(s1). 38–40. 29 indexed citations
5.
Cornell, Roger C.. (1992). Reply. Journal of the American Academy of Dermatology. 26(1). 143–143. 1 indexed citations
6.
Cornell, Roger C., Hubert T. Greenway, Stephen B. Tucker, et al.. (1990). Intralesional interferon therapy for basal cell carcinoma. Journal of the American Academy of Dermatology. 23(4). 694–700. 141 indexed citations
7.
Bickers, David R., et al.. (1988). Clobetasol Propionate Ointment Once Daily Versus Fluocinonide Ointment Three Times Daily in Psoriasis. International Journal of Dermatology. 27(1). 54–55. 1 indexed citations
8.
Willis, Isaac, Roger C. Cornell, Neal S. Penneys, & Nardo Zaias. (1986). Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.. PubMed. 8(3). 275–82. 5 indexed citations
9.
Jacobson, Coleman, et al.. (1986). A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.. PubMed. 37(3). 213–4, 216, 218. 24 indexed citations
10.
Greenway, Hubert T., et al.. (1986). Treatment of basal cell carcinoma with intralesional interferon. Journal of the American Academy of Dermatology. 15(3). 437–443. 127 indexed citations
11.
Cornell, Roger C.. (1985). Correlation of the Vasoconstriction Assay and Clinical Activity in Psoriasis. Archives of Dermatology. 121(1). 63–63. 95 indexed citations
12.
Cornell, Roger C. & Richard B. Stoughton. (1984). The Use of Topical Steroids in Psoriasis. Dermatologic Clinics. 2(3). 397–409. 23 indexed citations
13.
Cornell, Roger C. & Richard B. Stoughton. (1981). Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis. British Journal of Dermatology. 105(1). 91–95. 25 indexed citations
14.
Cornell, Roger C. & Richard B. Stoughton. (1980). Use of glucocorticosteroids in psoriasis. Pharmacology & Therapeutics. 11(3). 497–508. 8 indexed citations
15.
Crawford, William, Irving P. Crawford, Richard B. Stoughton, & Roger C. Cornell. (1979). Laboratory Induction and Clinical Occurrences of Combined Clindamycin and Erythromycin Resistance in Corynebacterium acnes. Journal of Investigative Dermatology. 72(4). 187–190. 86 indexed citations
16.
Ring, Johannes, et al.. (1979). Plasma complement and histamine changes in atopic dermatitis*. British Journal of Dermatology. 100(5). 521–530. 35 indexed citations
17.
Ring, Johannes, et al.. (1978). Complement and immunoglobulin deposits in the skin of patients with atopic dermatitis. British Journal of Dermatology. 99(5). 495–501. 32 indexed citations
18.
Cornell, Roger C.. (1976). Anemia of Azaribine in the Treatment of Psoriasis. Archives of Dermatology. 112(12). 1717–1717. 4 indexed citations
19.
Cornell, Roger C., et al.. (1973). Urine Orotic Acid-Orotidine Levels in Azaribine-Treated Patients with Psoriasis. Journal of Investigative Dermatology. 61(3). 183–187. 4 indexed citations
20.
Cornell, Roger C., et al.. (1973). Diurnal Mitotic Studies of Psoriatic Epidermis. Journal of Investigative Dermatology. 61(3). 180–182. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.D. Ormerod Breakdown of academic impact, for papers by Victor H. Witten Breakdown of academic impact, for papers by Jann Lübbe Breakdown of academic impact, for papers by Dagmar Wilsmann‐Theis Breakdown of academic impact, for papers by Morad Lahfa Breakdown of academic impact, for papers by Annunziata Raimondo Breakdown of academic impact, for papers by Rita V. Patel Breakdown of academic impact, for papers by M. J. D. Goodfield Breakdown of academic impact, for papers by Андрис Рубинс Breakdown of academic impact, for papers by Nordwig S. Tomi
Rankless by CCL
2026